NOTCH3 p.R544C Drives Early Neurovascular Unit Dysfunction through Blood-Brain Barrier Failure, Complement Signalling and Metabolic Dysregulation

Cerebral small vessel disease is a major cause of stroke and vascular cognitive impairment, yet the mechanisms that initiate neurovascular dysfunction before irreversible brain injury remain poorly defined. CADASIL, caused by cysteine-altering NOTCH3 mutations, provides a genetically tractable model to resolve these early events. Here, we investigated the Asian-enriched NOTCH3 p.R544C variant and tested whether early disease emerges through interconnected blood-brain barrier (BBB), inflammatory, and metabolic dysfunction. NOTCH3 p.R544C iPSC-derived endothelial cells showed impaired angiogenesis and migration, reduced barrier resistance, disrupted tight-junction organisation, and altered vascular, adhesion, and extracellular-matrix programmes. In multicellular BBB-like microtissues, these defects propagated across the neurovascular unit, producing disorganised vascular networks, enlarged luminal structures, and increased permeability, establishing BBB failure as an early disease layer. Single-cell transcriptomics revealed coordinated loss of endothelial BBB transport and efflux programmes with astrocytic complement, innate immune, and matrix-remodelling activation. Secretome profiling and patient-plasma measurements converged on complement- and matrix-associated mediators, including C1S and CLU, identifying complement-matrix activation as a second interconnected layer. Importantly, combined cilostazol and isosorbide mononitrate treatment improved barrier function and reduced selected complement- and matrix-associated proteins in mutant microtissues, supporting pharmacological reversibility of components of this early disease programme. Seahorse analysis further demonstrated reduced mitochondrial respiratory capacity associated with NOTCH3 p.R544C. In vivo, three-month-old mutant mice showed altered cerebral pyruvate metabolism and early microvascular abnormalities, whereas six-month-old mice developed more prominent extracellular-matrix, inflammatory, and gliovascular changes, supporting an age-dependent transition from early metabolic dysregulation to broader neurovascular remodelling. Together, these findings define NOTCH3 p.R544C CADASIL as an early multicellular neurovascular disorder organised across three interconnected mechanistic layers: BBB failure, complement-matrix signalling, and metabolic dysregulation, while identifying early BBB-centred dysfunction as a potentially tractable state before advanced cerebrovascular injury develops.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-20
DOI
https://doi.org/10.64898/2026.11.17.767474
Primary Topic
Barrier Structure and Function Studies
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

NOTCH3 p.R544C Drives Early Neurovascular Unit Dysfunction through Blood-Brain Barrier Failure, Complement Signalling and Metabolic Dysregulation

Christine Cheung, Jolene Wei Ling Lee, Adeline Su Lyn Ng, Alicia Qian Ler Tan et al.
bioRxiv (Cold Spring Harbor Laboratory)
Barrier Structure and Function Studies
preprint

NOTCH3 p.R544C Drives Early Neurovascular Unit Dysfunction through Blood-Brain Barrier Failure, Complement Signalling and Metabolic Dysregulation

Christine Cheung, Jolene Wei Ling Lee, Adeline Su Lyn Ng, Alicia Qian Ler Tan, Laurie H. Sanders, Eng‐King Tan, Li Zeng, Zhen‐Kai Ngian, Qunxiang Ong, Pei Zhong, Zhiwei Zhang, Monika Chauhan, Xing Qi Teo, Tse Siew Lim, Hannah Su-Ann Wee
preprint en

Abstract

Cerebral small vessel disease is a major cause of stroke and vascular cognitive impairment, yet the mechanisms that initiate neurovascular dysfunction before irreversible brain injury remain poorly defined. CADASIL, caused by cysteine-altering NOTCH3 mutations, provides a genetically tractable model to resolve these early events. Here, we investigated the Asian-enriched NOTCH3 p.R544C variant and tested whether early disease emerges through interconnected blood-brain barrier (BBB), inflammatory, and metabolic dysfunction. NOTCH3 p.R544C iPSC-derived endothelial cells showed impaired angiogenesis and migration, reduced barrier resistance, disrupted tight-junction organisation, and altered vascular, adhesion, and extracellular-matrix programmes. In multicellular BBB-like microtissues, these defects propagated across the neurovascular unit, producing disorganised vascular networks, enlarged luminal structures, and increased permeability, establishing BBB failure as an early disease layer. Single-cell transcriptomics revealed coordinated loss of endothelial BBB transport and efflux programmes with astrocytic complement, innate immune, and matrix-remodelling activation. Secretome profiling and patient-plasma measurements converged on complement- and matrix-associated mediators, including C1S and CLU, identifying complement-matrix activation as a second interconnected layer. Importantly, combined cilostazol and isosorbide mononitrate treatment improved barrier function and reduced selected complement- and matrix-associated proteins in mutant microtissues, supporting pharmacological reversibility of components of this early disease programme. Seahorse analysis further demonstrated reduced mitochondrial respiratory capacity associated with NOTCH3 p.R544C. In vivo, three-month-old mutant mice showed altered cerebral pyruvate metabolism and early microvascular abnormalities, whereas six-month-old mice developed more prominent extracellular-matrix, inflammatory, and gliovascular changes, supporting an age-dependent transition from early metabolic dysregulation to broader neurovascular remodelling. Together, these findings define NOTCH3 p.R544C CADASIL as an early multicellular neurovascular disorder organised across three interconnected mechanistic layers: BBB failure, complement-matrix signalling, and metabolic dysregulation, while identifying early BBB-centred dysfunction as a potentially tractable state before advanced cerebrovascular injury develops.

bioRxiv (Cold Spring Harbor Laboratory)
Agency for Science, Technology and Research (SG), Sun Yat-sen University (CN), Duke University (US), National Neuroscience Institute (SG)
Barrier Structure and Function Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon